Immunization, Hib3 (% of children ages 12-23 months) in Turkmenistan
Turkmenistan: Immunization, Hib3 (% of children ages 12-23 months) was 98.0% in 2024. ▲ Rising
Immunization, Hib3 in Turkmenistan, 2010–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
Turkmenistan recorded 98.0% for immunization, hib3 in 2024.
Compared with earlier readings it is up 1.0% over ten years.
Over the whole period, immunization, hib3 in Turkmenistan peaked at 99.0% in 2015 and was at its lowest, 58.0%, in 2010.
That places Turkmenistan 20th out of 191 countries with data for 2024, putting it in the top 10%.
The long-run direction has been consistently rising across the 15 years of available data.
Immunization, Hib3 (% of children ages 12-23 months) in Turkmenistan, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2010 | 58.0% | — |
| 2011 | 71.0% | +22.4% |
| 2012 | 97.0% | +36.6% |
| 2013 | 97.0% | +0.0% |
| 2014 | 97.0% | +0.0% |
| 2015 | 99.0% | +2.1% |
| 2016 | 98.0% | -1.0% |
| 2017 | 99.0% | +1.0% |
| 2018 | 99.0% | +0.0% |
| 2019 | 99.0% | +0.0% |
| 2020 | 99.0% | +0.0% |
| 2021 | 97.0% | -2.0% |
| 2022 | 98.0% | +1.0% |
| 2023 | 98.0% | +0.0% |
| 2024 | 98.0% | +0.0% |
Turkmenistan compared with similar countries
- Turkmenistan's 98.0% is above the median for upper middle income countries, which is 91.0%, 1.1× the median. (57 countries reporting)
- Turkmenistan's 98.0% is above the median for Europe & Central Asia, which is 94.0%, 1.0× the median. (50 countries reporting)
Biggest year-on-year movements
Years where Immunization, Hib3 (% of children ages 12-23 months) in Turkmenistan changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2012 | +36.6% | 71.0% | 97.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 91.4% | 58.0% | 99.0% | 10 |
| 2020s | 98.0% | 97.0% | 99.0% | 5 |
Countries ranked near Turkmenistan
More health data for Turkmenistan
- Un projection of annual infant deaths, annual growth rate -1.61 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4813 % change on previous year (2090)
- Un projection of annual infant deaths 549 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.49 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0499 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.48 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0527 units per person (2025)
Frequently asked questions
- What is immunization, hib3 in Turkmenistan?
- Immunization, hib3 in Turkmenistan was 98.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Turkmenistan?
- The highest recorded value was 99.0% in 2015.
- What is the lowest immunization, hib3 recorded in Turkmenistan?
- The lowest recorded value was 58.0% in 2010.
- How does Turkmenistan rank for immunization, hib3?
- Turkmenistan ranks 20th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Turkmenistan?
- Over the last ten years it is up 1.0%. The long-run trend across the full record is rising.
- Where does this Turkmenistan data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.